Companies: 10,795·Total market cap: $144.5T
BioAtla, Inc.

BioAtla, Inc.

BCABNASDAQHealthcare● Active
$3.31
$-0.02(-0.60%)
Market Cap$4174023
P/E Ratio
52W High$71.5
52W Low$3.12
Overview

BioAtla, Inc. (BCAB) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · BCAB · as of Mar 31, 2026

Latest filing snapshot

41
-20-32.79%vs prior year

BioAtla, Inc. (BCAB) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
41
Change (1Y)
-20
Growth % (1Y)
-32.79%
Revenue / Employee
$48.8K
Net Income / Employee
$-1.45M
Market Cap
$4M

BCAB Employee Count

2020 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-3141-20-32.79%
2025-03-2861-4-6.15%
2024-03-2665-1-1.52%
2023-03-2366+10+17.86%
2022-02-2856+20+55.56%
2021-03-2436

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Celularity Inc.
CELU
Celularity Inc.
120
#2
Generation Bio Co.
GBIO
Generation Bio Co.
115
#3
Mersana Therapeutics, Inc.
MRSN
Mersana Therapeutics, Inc.
102
#4
Evaxion Biotech A/S
EVAX
Evaxion Biotech A/S
46
#5
BioAtla, Inc.
BCAB
BioAtla, Inc.YOU
41
#6
BioXcel Therapeutics, Inc.
BTAI
BioXcel Therapeutics, Inc.
37
#7
Annovis Bio, Inc.
ANVS
Annovis Bio, Inc.
8
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · BCAB peer comparison

About BCAB employees

BCAB Employees · Headcount

BioAtla, Inc. (BCAB) employee data is sourced from the annual SEC 10-K filing. As of 2025, BioAtla, Inc. had 41 full-time employees globally. Full-time employees only. Global consolidated headcount.

BioAtla, Inc. employs 41 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $48,780, reflecting the company's operational efficiency.

BioAtla, Inc.'s workforce decreased by 20 (32.79%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

BioAtla, Inc.'s revenue per employee of $48,780 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

BCAB Employees · 5 questions

As of the latest SEC 10-K filing (2025), BioAtla, Inc. had 41 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

BioAtla, Inc. employee counthow many employees does BioAtla, Inc. haveBCAB total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-31